Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Late stage assay provider results from the probe development effort to identify inhibitors of PP5: fluorescence-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of OMFP by PP5 (Round 5)
Assay data:7 Active, 7 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP5: radiolabel-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP1 (Round 5)
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP5: radiolabel-based biochemical assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP2A (Round 5)
Assay data:7 Tested
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP5: radiolabel-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP5 (Round 5)
Assay data:5 Active, 8 Tested
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP5: fluorescence-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of OMFP by PP2C-alpha (Round 5)
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP5: radiolabel-based biochemical assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP1 (Round 5)
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP5: fluorescence-based biochemical assay to determine activity of inhibitors on dephosphorylation of OMFP by PP1 (Round 5)
Assay data:11 Tested
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP5: radiolabel-based biochemical assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP5 (Round 5)
Assay data:6 Active, 36 Tested
Late stage assay provider results from the probe development effort to identify inhibitors of PP5: fluorescence-based biochemical assay to determine activity of inhibitors on dephosphorylation of OMFP by PP5 (Round 5)
Assay data:14 Active, 25 Tested
Late stage assay provider results from the probe development effort to identify inhibitors of PP5: fluorescence-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of OMFP by PP5 (Round 5) (3.8nM low dose)
Assay data:4 Active, 7 Tested
Late stage assay provider results from the probe development effort to identify inhibitors of PP5: fluorescence-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of OMFP by PP5 (Round 5) (12.7 nM low dose)
Assay data:2 Tested
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP5: radiolabel-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP2A (Round 5)
Summary of probe development efforts to identify inhibitors of protein phosphatase 1 (PP1)
Late stage assay provider results from the probe development effort to identify inhibitors of PP5: radiolabel-based biochemical counterscreen assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP1
Assay data:1 Active, 3 Tested
Late stage assay provider results from the probe development effort to identify inhibitors of PP5: radiolabel-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP5
Assay data:2 Active, 3 Tested
Late stage assay provider results from the probe development effort to identify inhibitors of PP5: radiolabel-based biochemical assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP5
Assay data:4 Active, 64 Tested
Late stage assay provider results from the probe development effort to identify inhibitors of PP5: fluorescence-based biochemical assay to determine activity of inhibitors on dephosphorylation of OMFP by PP5
Assay data:4 Active, 65 Tested
Fluorescence-based biochemical high throughput dose response assay for inhibitors of Protein Phosphatase 5 (PP5)
Assay data:31 Active, 4 Activity ≤ 1 µM, 60 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).
Assay data:2846 Active, 315101 Tested
Summary of probe development efforts to identify inhibitors of Protein Phosphatase 5 (PP5).
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on